Clinical trials
Sleep Initiation and Maintenance Disorders trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 4 |
| Leiden University Medical Center | 3 |
| VU University of Amsterdam | 3 |
| Janssen Research & Development, LLC | 2 |
| Utrecht University | 2 |
| Catharina Ziekenhuis Eindhoven | 1 |
| Idorsia Pharmaceuticals Ltd. | 1 |
| Jaap Lancee | 1 |
| Leiden University | 1 |
| Maastricht University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Initiation and Maintenance Disorders | 28 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Chronobiology Disorders | 1 |
| Dyspnea | 1 |
| Hodgkin Disease | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Major Depressive Disorder | 1 |
| Multiple Sclerosis | 1 |
| Obesity | 1 |
| Overweight | 1 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.